Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor.

Journal of Medicinal Chemistry
Matthew P EpplinDennis C Liotta

Abstract

The N-methyl-d-aspartate receptor (NMDAR) is an ion channel that mediates the slow, Ca2+-permeable component of glutamatergic synaptic transmission in the central nervous system (CNS). NMDARs are known to play a significant role in basic neurological functions, and their dysfunction has been implicated in several CNS disorders. Herein, we report the discovery of second-generation GluN2C/D-selective NMDAR-positive allosteric modulators (PAMs) with a dihydropyrrolo[1,2-a]pyrazin-3(4H)-one core. The prototype, R-(+)-EU-1180-453, exhibits log unit improvements in the concentration needed to double receptor response, lipophilic efficiency, and aqueous solubility, and lowers cLogP by one log unit compared to the first-generation prototype CIQ. Additionally, R-(+)-EU-1180-453 was found to increase glutamate potency 2-fold, increase the response to maximally effective concentration of agonist 4-fold, and the racemate is brain-penetrant. These compounds are useful second-generation in vitro tools and a promising step toward in vivo tools for the study of positive modulation of GluN2C- and GluN2D-containing NMDA receptors.

References

Oct 1, 1988·Annals of Neurology·C K ParkJ McCulloch
Jan 7, 1993·Nature·T V Bliss, G L Collingridge
Sep 15, 1999·Nature·Y P TangJ Z Tsien
Jan 11, 2000·Journal of Psychiatric Research·J W OlneyN B Farber
Feb 25, 2000·Biological Psychiatry·R M BermanJ H Krystal
Jul 13, 2000·Journal of Medicinal Chemistry·F Yoshida, J G Topliss
Mar 16, 2001·Neuropharmacology·M CecconS Vicini
Jan 14, 2003·Nature Neuroscience·Tue G Banke, Stephen F Traynelis
Apr 4, 2003·The New England Journal of Medicine·Barry ReisbergUNKNOWN Memantine Study Group
Dec 20, 2003·Annals of the New York Academy of Sciences·Joseph T CoyleDonald Goff
May 28, 2004·Pharmacology & Therapeutics·Penelope J Hallett, David G Standaert
Feb 17, 2007·The Journal of Physiology·Shashank M DravidStephen F Traynelis
Apr 4, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David M BannermanJohn N P Rawlins
Jul 19, 2008·The Journal of Physiology·Shashank M DravidStephen F Traynelis
Sep 2, 2009·Bioorganic & Medicinal Chemistry Letters·Ted W JohnsonMartin Edwards
Oct 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Long-Jun Wu, Min Zhuo
Oct 27, 2009·European Archives of Psychiatry and Clinical Neuroscience·Andrea SchmittFritz A Henn
Nov 10, 2009·Biological Psychiatry·Marije aan het RotSanjay J Mathew
Apr 30, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ethan G HughesRita J Balice-Gordon
Aug 19, 2010·Pharmacological Reviews·Stephen F TraynelisRay Dingledine
Sep 21, 2010·Trends in Neurosciences·Austen J Milnerwood, Lynn A Raymond
Oct 29, 2010·Nature Communications·Praseeda MullasserilStephen F Traynelis
Nov 6, 2010·Pharmaceutical Research·Xiangli LiuAlfred Fahr
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bita Moghaddam, Daniel Javitt
Jan 17, 2012·Nature Neuroscience·Beth Siegler RetchlessJon W Johnson
Feb 23, 2012·Schizophrenia Bulletin·Guillermo Gonzalez-Burgos, David A Lewis
May 1, 2012·Brain : a Journal of Neurology·Lenka MikasovaLaurent Groc
May 30, 2012·The Journal of Physiology·Katie M VanceStephen F Traynelis
Jun 16, 2012·Nature·Michael J SchmeisserTobias M Boeckers
Jul 17, 2012·Neuropharmacology·Graham L CollingridgeDavid E Jane

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.